NMS exits clinical trial firm Flourish Research

NMS formed Flourish in 2021 through its initial investment in Clinical Trials of Texas.

7 November 2024•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America US Healthcare Briefs